Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
Actual shortage: | 15 (2%) | |
Anticipated shortage: | 4 (1%) | |
Avoided shortage: | 85 (13%) | |
Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 234 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
1 (5%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-12-23 | 2022-05-11 | 130644 |
FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
VITAMIN C | 500MG | SOLUTION | Resolved | 2021-06-01 | 2021-06-08 | 140155 |
MYLAN-LATANOPROST | 50MCG | SOLUTION | Resolved | 2022-03-15 | 2022-03-30 | 156728 |
PYRIDOXINE HYDROCHLORIDE INJECTION, USP | 100MG | SOLUTION | Avoided shortage | 2022-09-01 | 2022-09-26 | 168389 |
MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2022-11-29 | 2023-01-17 | 176221 |
MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2023-01-17 | 2023-05-25 | 181289 |
VITAMIN C | 500MG | SOLUTION | Resolved | 2023-02-14 | 2023-03-02 | 184576 |
VITAMIN C | 500MG | SOLUTION | Resolved | 2023-04-20 | 2023-07-18 | 189880 |
VITAMIN C | 500MG | SOLUTION | Actual shortage | 2023-10-17 | 2024-05-30 | 207192 |
PYRIDOXINE HYDROCHLORIDE INJECTION, USP | 100MG | SOLUTION | Avoided shortage | 2023-12-19 | 2024-01-10 | 213767 |
MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Resolved | 2017-09-22 | 2020-01-21 | 23166 |
MYLAN-BUDESONIDE AQ | 64MCG | SPRAY, METERED DOSE | Resolved | 2017-09-22 | 2020-03-04 | 23169 |
MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Resolved | 2020-02-04 | 2020-03-04 | 105234 |
MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Actual shortage | 2023-02-23 | 2023-12-12 | 185423 |
MYLAN-BUDESONIDE AQ | 64MCG | SPRAY, METERED DOSE | Actual shortage | 2023-03-07 | 2023-12-12 | 186402 |
MYLAN-BECLO AQ | 50MCG | SUSPENSION METERED-DOSE AEROSOL | Resolved | 2023-08-29 | 2024-02-29 | 203100 |
MYLAN-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-10 | 2018-07-05 | 125 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2019-01-18 | 189 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 191 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55130 |
MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |